The Guidelines applies to changes to the manufacturing process of active pharmaceutical ingredients and finished chemical drug products. 

Based on the possible influence on the products' safety, efficacy, and quality controllability, the changes are classified into three categories: 

1. Category I: minor changes;

2. Category II: moderate changes;

3. Category III: major changes.